Human coagulation factor viii/von willebrand factor complex
Voncento (human coagulation factor viii/von willebrand factor complex) is an unknown pharmaceutical. Human coagulation factor viii/von willebrand factor complex was first approved as Voncento on 2013-08-12. It has been approved in Europe to treat hemophilia a and von willebrand diseases.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
77 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemophilia a | D006467 | EFO_0007267 | D66 | 7 | 3 | 24 | 11 | 21 | 65 |
| Von willebrand diseases | D014842 | D68.0 | — | 1 | 3 | 2 | 3 | 9 | |
| Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | 1 | 1 | 2 | 4 |
| Hemophilia b | D002836 | D67 | — | — | 1 | 1 | — | 2 | |
| Hematologic diseases | D006402 | EFO_0005803 | D75.9 | — | — | — | 1 | 1 | 2 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | 1 | — | 1 |
| Blood platelet disorders | D001791 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Joint diseases | D007592 | HP_0003040 | M12.9 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX |
| INN | — |
| Description | Voncento (human coagulation factor viii/von willebrand factor complex) is an unknown pharmaceutical. Human coagulation factor viii/von willebrand factor complex was first approved as Voncento on 2013-08-12. It has been approved in Europe to treat hemophilia a and von willebrand diseases. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4298129 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 33 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
541 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more